NDC 0074-3878 – Emblaveo

Aztreonam 127 mg/mL; Avibactam 42.3 mg/mL · Powder, For Solution · Intravenous

Human Prescription Drug

Product NDC0074-3878

Product details

Brand name
Emblaveo
Generic name
Aztreonam and avibactam
Labeler
AbbVie Inc.
Dosage form
Powder, For Solution
Route
Intravenous
Marketing category
NDA · NDA217906
Marketed since
February 7, 2025
Listing expires
December 31, 2027
Pharmacologic class
Monobactam Antibacterial; beta Lactamase Inhibitor

Active ingredients

Uses, dosage, side effects and warnings for Emblaveo →

Package NDC codes (1)

Package NDCDescriptionSince
0074-3878-1010 VIAL, SINGLE-DOSE in 1 CARTON (0074-3878-10) / 12 mL in 1 VIAL, SINGLE-DOSE (0074-3878-01)Feb 7, 2025